Total Return:17.53%(TTM)
Over the latest trailing 12-month period, total return cagr is +17.53%. The comparable SPY value is +22.28%. Year-to-date total return is +19.89%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in DGX
$830,516
(83.1x return)
Invested on Dec 17, 1996
Growth of $10,000 in SPY (S&P 500)
$160,685
(16.1x return)
Invested on Dec 17, 1996
Hypothetical Growth of $10,000
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
Recent Performance Indicators
YTD Total Return
+19.9%
1-Year Total Return
+17.5%
Current Dividend Yield
1.58%
Price CAGR vs. Total Return CAGR
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +15.4% | +17.5% | +2.1% |
| 3 Years | +13.3% | +15.6% | +2.3% |
| 5 Years | +9.7% | +11.9% | +2.2% |
| 10 Years | +10.1% | +12.3% | +2.2% |
| 15 Years | +8.7% | +10.8% | +2.1% |
| 20 Years | +6.5% | +8.3% | +1.8% |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis